🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Theresa A. Boyle

Moffitt Cancer Center

ORCID: 0000-0001-5950-3970
Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 12 papers. Top paper: “Phase I Study of Taminadenant (PBF509/NIR178), an Adenosine 2A Receptor Antagonist, with or without Spartalizumab (PDR001), in Patients with Advanced Non–Small Cell Lung Cancer”.

Phase I Study of Taminadenant (PBF509/NIR178), an Adenosine 2A Receptor Antagonist, with or without Spartalizumab (PDR001), in Patients with Advanced Non–Small Cell Lung Cancer

Clinical Cancer Research(2022)10.1158/1078-0432.ccr-21-2742
N/A
1.8DataRank · unranked
70 citations

Ben Creelan, Tawee Tanvetyanon, Jhanelle E. Gray, Eric B. Haura, Ram Thapa +13 more

Integrated Proteomics-Based Physical and Functional Mapping of AXL Kinase Signaling Pathways and Inhibitors Define Its Role in Cell Migration

Molecular Cancer Research(2022)10.1158/1541-7786.mcr-21-0275
N/A
0DataRank · unranked
11 citations

Sina Hosseinian, Mia Stroud, Emma Adhikari, James J. Saller, Matthew A. Smith +14 more

Combination IFNβ and Membrane-Stable CD40L Maximize Tumor Dendritic Cell Activation and Lymph Node Trafficking to Elicit Systemic T-cell Immunity

Cancer Immunology Research(2023)10.1158/2326-6066.cir-22-0927
N/A
0DataRank · unranked
17 citations

Xiaoqing Yu, Mohammed L. Ibrahim, Dana Foresman, Mengyu Xie, Joseph Johnson +9 more

Grading of lung adenocarcinomas with simultaneous segmentation by artificial intelligence (GLASS-AI)

npj Precision Oncology(2023)10.1038/s41698-023-00419-3
N/A
0DataRank · unranked
12 citations

Hayley D. Ackerman, Kyubum Lee, Mahmoud A. Abdalah, Andrew John Davis, Nicole Hackel +10 more

Data from Phase I Study of Taminadenant (PBF509/NIR178), an Adenosine 2A Receptor Antagonist, with or without Spartalizumab (PDR001), in Patients with Advanced Non–Small Cell Lung Cancer

(2023)10.1158/1078-0432.c.6531020
N/A
0DataRank · unranked
0 citations

Ben Creelan, Tawee Tanvetyanon, Jhanelle E. Gray, Eric B. Haura, R. K. Thapa +13 more

Data from Phase I Study of Taminadenant (PBF509/NIR178), an Adenosine 2A Receptor Antagonist, with or without Spartalizumab (PDR001), in Patients with Advanced Non–Small Cell Lung Cancer

(2023)10.1158/1078-0432.c.6531020.v1
N/A
0DataRank · unranked
0 citations

Ben Creelan, Tawee Tanvetyanon, Jhanelle E. Gray, Eric B. Haura, R. K. Thapa +13 more

Lurbinectedin sensitizes PD-L1 blockade therapy by activating STING-IFN signaling in small-cell lung cancer

Cell Reports Medicine(2024)10.1016/j.xcrm.2024.101852
N/A
0DataRank · unranked
11 citations

Utsav Sen, Kedwin Ventura, Vrinda Jethalia, Charles Coleman, Subhasree Sridhar +13 more

Early-Life Social Determinants of SCA6 Age at Onset, Severity, and Progression

The Cerebellum(2024)10.1007/s12311-023-01655-w
N/A
0DataRank · unranked
4 citations

Hannah Casey, Chi‐Ying Lin, Theresa A. Boyle, Jeremy D. Schmahmann, Gilbert L’Italien +3 more

Rapid Autopsy to Define Dendritic Cell Spatial Distribution and T Cell Association in Lung Adenocarcinoma

The Journal of Immunology(2024)10.4049/jimmunol.2400234
N/A
0DataRank · unranked
0 citations

Xiaofei Song, Gina S. Nazario, Thomas Lila, Benjamin K. Chen, Tyler R. Simpson +13 more

Lurbinectedin sensitizes PD-L1 blockade therapy by activating STING-IFN signaling in small-cell lung cancer

Cell Reports Medicine(2025)10.1016/j.xcrm.2025.101944
N/A
0DataRank · unranked
3 citations

Utsav Sen, Kedwin Ventura, Vrinda Jethalia, Charles Coleman, Subhasree Sridhar +13 more

Nicotinamide nucleotide transhydrogenase regulates mitochondrial metabolism in NSCLC through maintenance of Fe-S protein function

The Journal of Experimental Medicine(2020)10.1084/jem.20191689
N/A
0DataRank · unranked
54 citations

Yun Pyo Kang, Aimee Falzone, Theresa A. Boyle, Gina M. DeNicola, Nathan P. Ward

Multifactorial stroma-mediated resistance is a major contributor to residual disease under targeted therapies in lung cancers

Research Square(2025)10.21203/rs.3.rs-6264377/v1
N/A
0DataRank · unranked
3 citations

Bina Desai, Tatiana Miti, Sandhya Prabhakaran, Daria Miroshnychenko, M Henry +12 more